| Use of TheraSphere® Yttrium-90 Glass Microspheres for Primary and Metastatic Liver Tumors (NCT00493883) | Southwestern Regional Medical Center | 2006-12-01 |
| A Phase II Study of Tegafur/Uracil (UFUR®)Plus Thalidomide for the Treatment of Advanced or Metastatic Hepatocellular Carcinoma (HCC) (NCT00384800) | Far Eastern Memorial Hospital | 2006-09-01 |
| Phase II Trial of Capecitabine for the Treatment of Unresectable/ Metastatic or Advanced Hepatocellular Carcinoma(HCC) (NCT00464295) | Aga Khan University | 2006-08-01 |
| Laser Interstitial Thermal Therapy Under "Real Time" MRI Guidance for "Minimal Invasive" Treatment of Liver Metastasis (NCT00392366) | BioTex, Inc. | 2006-07-01 |
| A Phase 3 Study of Talaporfin Sodium and Interstitial Light Emitting Diodes Treating Hepatocellular Carcinoma (HCC) (NCT00355355) | Light Sciences Oncology | 2006-07-01 |
| Phase III Study of BAY43-9006 in Patients With Advanced Hepatocellular Carcinoma (HCC) Treated After Transcatheter Arterial Chemoembolization (TACE) (NCT00494299) | Bayer | 2006-04-01 |
| A Randomized, Double-Blinded, Placebo-Controlled Study of Sorafenib in Patients With Advanced Hepatocellular Carcinoma (NCT00492752) | Bayer | 2005-10-01 |
| Trial for Hepatocellular Carcinoma Adjuvant Treatment by Lipiocis (NCT00116454) | ANRS, Emerging Infectious Diseases | 2005-07-01 |
| A Study Comparing Radiofrequency Ablation and Hepatic Resection for Hepatocellular Carcinoma (NCT02482909) | Seoul National University Hospital | 2005-07-01 |
| Cytotoxicity Induced by Tumor Lysate Pulsed Dendritic Cells Against Autologous Hepatocellular Carcinoma Cells (NCT00327496) | Mackay Memorial Hospital | 2005-06-01 |
| A Research Study to Treat Patients With Advanced Hepatocellular Carcinoma (NCT00108953) | Bayer | 2005-04-01 |
| Tumor Ablation With Talaporfin Sodium and Interstitial Light Emitting Diodes Treating Hepatocellular Carcinoma (HCC) (NCT00122876) | Light Sciences Oncology | 2005-04-01 |
| A Phase III Study of Sorafenib in Patients With Advanced Hepatocellular Carcinoma (NCT00105443) | Bayer | 2005-03-01 |
| A Study of Capecitabine (Xeloda) and Peginterferon Alfa-2a (Pegasys) in Treatment-Naive Participants With Advanced Liver Cancer (NCT02576964) | Hoffmann-La Roche | 2005-01-01 |
| The Effect of Viral Load on Intrahepatic Recurrence in Hepatitis B Virus (HBV)-Related Hepatocellular Carcinoma (HCC) (NCT00397540) | Seoul National University Hospital | 2004-10-01 |
| A Phase II Protocol of Arsenic Trioxide (Trisenox) in Subjects With Advanced Primary Carcinoma of the Liver (NCT00582400) | The University of Texas Medical Branch, Galveston | 2004-09-01 |
| Effect of Polymorphisms in the IL-1 Gene Complex on the Development of Chronic Hepatitis and Hepatocellular Carcinoma (NCT00155103) | National Taiwan University Hospital | 2004-08-01 |
| Oxaliplatin in Unresectable Hepatocellular Carcinoma (NCT00280618) | Sanofi | 2004-07-01 |
| PI-88 in Hepatocellular Carcinoma After Hepatectomy (NCT00247728) | Cellxpert Biotechnology Corp. | 2004-06-01 |
| Dose Escalation Study for Primary Hepatocellular Carcinoma (NCT00243841) | Indiana University | 2004-05-01 |
| A Comparative Study of the Efficacy of Transcatheter Arterial Chemoembolization (TACE) and Transcatheter Arterial Pegylated Interferon Embolization (TAIE) for Liver Cancer (NCT00563095) | Hospital Authority, Hong Kong | 2004-03-01 |
| A Safety and Efficacy Study of DENSPM in Patients With Liver Cancer Who Are Not Eligible for Surgical Care (NCT00081900) | Genzyme, a Sanofi Company | 2004-03-01 |
| Safety and Efficacy Study of a Caspase Inhibitor in Patients Undergoing Liver Transplantation (NCT00080236) | Conatus Pharmaceuticals Inc. | 2003-11-01 |
| Phase III Trial of Oral Thalidomide in Advanced Hepatocellular Carcinoma With Poor Liver Reserve (NCT00225290) | TTY Biopharm | 2003-02-01 |
| TK-based Suicide Gene Therapy for Hepatocellular Carcinoma (NCT00844623) | Clinica Universidad de Navarra, Universidad de Navarra | 2002-12-01 |
| Safety And Efficacy Of Irinotecan Plus Capecitabine As First-Line Treatment In Asian Subjects With Hepatocellular Carcinoma (NCT00635323) | Pfizer | 2002-11-01 |
| Testing of ADI-PEG in Hepatocellular Carcinoma (NCT00056992) | FDA Office of Orphan Products Development | 2002-09-01 |
| A Study to Estimate Safety and Efficacy of Sorafenib (BAY43-9006) in the Treatment of Hepatocellular Carcinoma (NCT00044512) | Bayer | 2002-08-01 |
| Pegylated Alfa-2b Interferon Therapy of Patients With Hepatitis C-related Cirrhosis and High Liver Cell Proliferation (P02733/MK-4031-085) (NCT00759109) | Merck Sharp & Dohme LLC | 2002-03-01 |
| Safety and Efficacy of Doxorubicin Adsorbed to Magnetic Beads Vs. IV Doxorubicin in Treating Liver Cancer (NCT00034333) | FeRx | 2002-03-01 |
| A National Registry of Patients With Hepatocellular Carcinoma (NCT00178867) | Vanderbilt University | 2002-01-01 |
| Risk Factors and Molecular Genomics of U.S. Patients With Chronic Liver Disease and Hepatocellular Cancer (NCT01034865) | Stanford University | 2001-05-01 |
| Comparison Between Radiofrequency Versus Ethanol Injection for the Treatment of Hepatocellular Carcinoma (NCT00355212) | Azienda Ospedaliera San Giovanni Battista | 2001-01-01 |
| Treatment of Hepatocellular Carcinoma: Long-Acting Somatostatin Plus Percutaneous Ethanol Instillation (PEI) Versus Long-Acting Somatostatin Alone (NCT00121914) | Medical University of Vienna | 2000-10-01 |
| Treatment of Hepatocellular Carcinoma With Tetrathiomolybdate (NCT00006332) | National Center for Research Resources (NCRR) | |
| East-West Hepatocellular Carcinoma Study Group (NCT01237132) | University of Milan | |
| Associating Liver Partition With Portal Vein Ligation For Staged Hepatectomy (ALPPS) or Portal Vein Occlusion in Treating Patients With Liver Cancer (NCT01722175) | Washington University School of Medicine | |
| A Trial of Thymalfasin in Adult Patients With Hepatocellular Carcinoma (NCT00082082) | SciClone Pharmaceuticals | |
| Therasphere® for Treatment of Unresectable Primary Liver Cancer and Metastatic Liver Cancer (NCT00701168) | Leo W. Jenkins Cancer Center | |